Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 1
1967 2
1969 1
1975 1
1998 2
1999 2
2000 2
2001 6
2002 5
2003 1
2004 1
2006 1
2007 1
2008 6
2009 4
2010 4
2011 3
2012 2
2013 1
2014 4
2015 1
2016 1
2017 1
2020 5
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.
Harrison TW, Chanez P, Menzella F, Canonica GW, Louis R, Cosio BG, Lugogo NL, Mohan A, Burden A, McDermott L, Garcia Gil E, Zangrilli JG; ANDHI study investigators. Harrison TW, et al. Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22. Lancet Respir Med. 2021. PMID: 33357499 Clinical Trial.
Safety of intranasal corticosteroids.
Bensch GW. Bensch GW. Ann Allergy Asthma Immunol. 2016 Dec;117(6):601-605. doi: 10.1016/j.anai.2016.06.009. Ann Allergy Asthma Immunol. 2016. PMID: 27979016 Review.
Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach.
Lugogo N, O'Connor M, George M, Merchant R, Bensch G, Portnoy J, Oppenheimer J, Castro M. Lugogo N, et al. Among authors: bensch g. Curr Allergy Asthma Rep. 2023 Nov;23(11):621-634. doi: 10.1007/s11882-023-01111-z. Epub 2023 Nov 22. Curr Allergy Asthma Rep. 2023. PMID: 37991672 Free PMC article. Review.
Recommendations for the pharmacologic management of allergic rhinitis.
Hoyte FC, Meltzer EO, Ostrom NK, Nelson HS, Bensch GW, Spangler DL, Storms WW, Weinstein SF, Katial RK. Hoyte FC, et al. Among authors: bensch gw. Allergy Asthma Proc. 2014 May-Jun;35 Suppl 1:S20-7. doi: 10.2500/aap.2014.35.3761. Allergy Asthma Proc. 2014. PMID: 25582158 Review.
Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.
Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, Jacobs JS, Kraft M, Martin RJ, Nair P, Wechsler ME. Katial RK, et al. Among authors: bensch gw. J Allergy Clin Immunol Pract. 2017 Mar-Apr;5(2S):S1-S14. doi: 10.1016/j.jaip.2016.11.029. Epub 2017 Jan 29. J Allergy Clin Immunol Pract. 2017. PMID: 28143691 Review.
Leukotriene modifiers in chronic urticaria.
Bensch G, Borish L. Bensch G, et al. Ann Allergy Asthma Immunol. 1999 Oct;83(4):348. doi: 10.1016/S1081-1206(10)62677-4. Ann Allergy Asthma Immunol. 1999. PMID: 10541429 Review. No abstract available.
59 results